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Abstract
Macrophage migration inhibitory factor (MIF) is known as a pluripotent immunoregulatory cytokine involved in T-cell
activation and inflammatory responses; however, no study on this protein in the peripheral nervous systems has been carried
out. We here demonstrated for the first time expression of MIF mRNA and MIF protein in rat sciatic nerves by reverse
transcription^polymerase chain reaction, Western blotting, and immunohistochemistry. Immunohistochemical analysis
revealed positive staining of MIF, which was largely observed in Schwann cells. Furthermore, we examined MIF mRNA
expression in the sciatic nerves by Northern blot analysis in the case of nerve transection. In both proximal and distal
segments, the level of MIF mRNA started to increase 12 h after the nerve transection. The level remained high from 24 h up
to day 7 after the injury. During the period from days 14 to 21, MIF mRNA sharply decreased to the pre-transection level. In
immunohistochemistry, positive staining of MIF was largely observed in axons as well as non-neuronal cells in proximal
segments at day 4 after transection. In the distal segments, contrastingly, endoneurial fibroblasts or Schwann cells migrating
into neuronal fibers showed positive staining with Wallerian degeneration. Although the precise functions of MIF in the
peripheral nerves remain to be elucidated, the present results could represent a major departure from the current state of
knowledge, revealing a novel function in the degenerative^regenerative process. ß 1999 Elsevier Science B.V. All rights
reserved.
Keywords: Immunohistochemistry; Macrophage migration inhibitory factor; Nerve injury; Sciatic nerve; Schwann cell
1. Introduction
Peripheral nerves have been identi¢ed as a rich
source of neurotrophic factors. Members of the neu-
rotrophin family such as nerve growth factor (NGF)
[1,2] and brain-derived neurotrophic factor (BDNF)
[3,4] are produced in the neuronal tissues and carried
by retrograde axonal transport. In contrast, a num-
ber of other neurotrophic factors, including ciliary
neurotrophic factor (CNTF) [5], insulin-like growth
factor (IGF)-1 [6], and leukemia inhibitory factor
(LIF) [7], are localized to non-neuronal cells, e.g.,
Schwann cells. In the case of peripheral nerve injury,
protein and mRNA levels of some neurotrophic fac-
tors show a characteristic chronological change de-
pending on their functions. For instance, the NGF
level markedly increases at non-neural Schwann cells
of the distal nerves after injury [8]. On the other
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hand, CNTF expression decreases dramatically after
axotomy [9,10]. In association with nerve tissue dam-
age, it has been demonstrated that macrophages are
profoundly involved in regulating the expression of
neurotrophic factors such as NGF [8] and IGF-1 [6]
during peripheral nerve regeneration. Macrophages
appear to up-regulate their levels indirectly by releas-
ing cytokines such as interleukin (IL)-1 [11] or di-
rectly by releasing neurotrophic factors [6].
The recruitment of macrophages from the periph-
eral vasculature is induced by chemoattractants re-
leased by in¢ltrating mononuclear cells. In the proc-
ess of recruitment, macrophage migration inhibitory
factor (MIF) was the ¢rst lymphokine reported to
prevent the random migration of macrophages out
of capillary tubes [12]. For more than 20 years, the
protein was considered to be expressed exclusively in
activated T lymphocytes. Since human MIF cDNA
was ¢rst cloned in 1989, previously unrecognized
sources of MIF have been reported [13]. In particu-
lar, it is of note that macrophages were found to be
the major source of MIF [14]. During our study on
MIF, we identi¢ed the presence of MIF outside the
immune system, including skin [15], ocular tissues
[16], bone [17], kidney [18] and vascular endothelial
cells [19]. In addition, we succeeded in the molecular
cloning of rat MIF cDNA, and reported its physio-
chemical properties [20^22].
In this study, we reveal for the ¢rst time the ex-
pression and localization of MIF in myelinated pe-
ripheral nerves using reverse transcription^polymer-
ase chain reaction (RT^PCR), Western blotting and
immunohistochemistry. Furthermore, we examined
the e¡ects of nerve transection on MIF expression
by Northern blotting and immunohistochemical
analysis, and discuss a possible role of this protein
during the process of nerve degeneration^regenera-
tion.
2. Materials and methods
2.1. Materials
The following materials were obtained from com-
mercial sources. Nitrocellulose membrane ¢lters were
purchased from Millipore (Bedford, MA): Isogen
RNA extraction kit from Nippon Gene (Tokyo, Ja-
pan); [K-32P]dCTP from Du-Pont NEN (Boston,
MA); M-MLV reverse transcriptase from Gibco
(Grand Island, NY); Taq DNA polymerase from
Perkin^Elmer (Norwalk, CT); Tissue-Tek OCT com-
pound from Miles Scienti¢c (Naperville, IL); Tween-
20 from Kanto (Tokyo, Japan); polyclonal rabbit
antibodies to bovine protein S-100 and bovine pro-
tein neuro¢lament from Wako (Tokyo, Japan);
horseradish peroxidase-conjugated goat anti-rabbit
antibody from Pierce (Rockford, IL); Vector ABC
kit from Vector Laboratories (Burlingame, CA);
3,3P-diaminobenzidine tetrahydrochloride from
Wako (Osaka, Japan), and Konica HRP-1000 immu-
nostaining kit from Konica (Tokyo, Japan). All oth-
er chemicals used were of analytical grade.
2.2. Preparation of antisera
Rat recombinant MIF was expressed in Escheri-
chia coli and puri¢ed to homogeneity as previously
described [21]. Polyclonal anti-rat MIF antiserum
was generated by immunizing New Zealand White
rabbits with puri¢ed recombinant MIF. In brief,
the rabbits were inoculated intradermally with 100
Wg of MIF diluted in complete Freund’s adjuvant
at weeks 1 and 2, and with 50 Wg of MIF in incom-
plete Freund’s adjuvant at week 4. Immune serum
was collected 1 week after the last inoculation. The
IgG fraction (4 mg/ml) was puri¢ed with Protein
A Sepharose according to the manufacturer’s proto-
col.
2.3. Surgical procedures
All experiments were carried out on male 10-week-
old Wistar King rats weighing around 300 g. The
animals were housed 3^5 per cage with controlled
temperature and a ¢xed lighting schedule (lights on
06.00^18.00 h). The rats were anesthetized with so-
dium pentobarbital (50 mg/kg, i.p.) and left sciatic
nerves were transected just distal to the obturator
tendon. To minimize axonal regeneration in trans-
ected nerves, distal ends of the axotomized nerve
were diverted into muscle tissues after the transec-
tion. The animals were killed at 0 h, 12 h, 24 h, 2,
4, 7, 14 and 21 days. All animal procedures were
approved by the Regulations for Animal Experi-
ments of Hokkaido University School of Medicine.
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2.4. Western blot analysis
To con¢rm the presence of MIF, Western blot
analysis was carried out. The euthanized rats were
perfused transcardially with 100 ml of saline to
eliminate blood from peripheral nerve tissues. Sci-
atic nerves were resected and connective tissues
excised. The nerve tissues were dissolved in 20 Wl of
Tris^HCl (50 mM, pH 6.8) containing 1% 2-mercap-
toethanol, 2% sodium dodecyl sulfate (SDS), 20%
glycerol and 0.04% bromophenol blue (BPB),
and heated at 100‡C for 5 min. The samples were
then subjected to SDS^polyacrylamide gel elec-
trophoresis (SDS^PAGE) as previously described
[23]. The electrophoresed proteins were transferred
onto a nitrocellulose sheet at 50 mA for 1 h using
a semi-dry blot transfer apparatus (Bio-Rad). The
sheet was thoroughly washed with phosphate buf-
fered saline (PBS), incubated with anti-rat MIF pol-
yclonal antibody (1:1000 dilution) for 1 h at room
temperature, and reacted with peroxidase-conjugated
anti-rabbit IgG serum (1:1000 dilution) for 1 h at
room temperature. After the reactions, the proteins
were visualized using Konica immunostaining HRP-
1000 as recommended in the manufacturer’s proto-
col.
2.5. RT^PCR
We performed RT^PCR analysis to con¢rm ex-
pression of MIF mRNA in peripheral nerves without
lesions. Total RNA was extracted from the nerve
tissue with an Isogen RNA extraction kit. The re-
verse transcription of the RNA was carried out
with M-MLV reverse transcriptase using oligo-dT
primer and subsequent ampli¢cation using Taq
DNA polymerase. PCR was carried out for 30 cycles
with denaturation at 94‡C for 1 min, annealing at
53‡C for 2 min and extension at 72‡C for 1 min using
a thermal cycler (Model 2400; Perkin^Elmer). MIF
primers used were 5P-TCATCGTGAACACCAA-
TGTTC-3P (11^31) (forward) and 5P-AGAACCG-
CAACTTACAGTAAGC-3P (215^236) (reverse). L-
Actin primers used were 5P-ATGGATGACGA-
TATCGCTG-3P (1^19) (forward) and 5P-ATGAGG-
TAGTCTGTCAGGT-3P (551^569) (reverse). After
PCR, the ampli¢ed products were analyzed by agar-
ose gel electrophoresis.
2.6. Immunohistochemistry
Animals were anesthetized and perfused transcar-
dially with 50 ml of saline followed by 100 ml of 4%
paraformaldehyde in 0.1 M sodium phosphate bu¡er
(pH 7.0). The intact sciatic nerve and distal and
proximal transected lesions of the nerve segments
were removed and post-¢xed in ¢xative containing
20% sucrose overnight at 4‡C. Five-mm sections
from injured nerves were cut from the tissues located
5^10 mm distal and proximal to the nerve stump,
embedded in OCT compound and snap frozen in
liquid nitrogen. Ten-Wm-thick frozen sections were
cut in a cryostat (Leica, model 1720), mounted on
poly-L-lysine-coated slides and air-dried at room
temperature. The slides were stored at 320‡C before
immunostaining.
The sections were pre-incubated for 1 h with PBS
containing 10% normal goat serum and 1% bovine
serum albumin to block non-speci¢c staining. The
rabbit anti-rat MIF polyclonal antibody, anti-bovine
S-100 polyclonal antibody and anti-mouse neuro¢la-
ment polyclonal antibody were applied to three ad-
jacent sections at dilutions of 1:500, 1:2000 and
1:1000, respectively, and incubated overnight at
4‡C After three washes with PBS containing
Tween-20, the slides were immersed in 100% metha-
nol containing 0.3% hydrogen peroxide for 30 min to
quench endogenous peroxidase reactivity. Then they
were stained with the avidin^biotin^peroxidase com-
plex procedure using a Histo¢ne SAB-PO Kit ac-
cording to the manufacturer’s protocol. In brief,
the slides were incubated with biotinylated goat
anti-rabbit IgG and avidin^biotin complex at room
temperature for 30 min. The reaction was developed
in 3,3P-diaminobenzidine tetrahydrochloride contain-
ing 0.01% hydrogen peroxide and the samples were
mounted with alkylacrylates.
2.7. Northern blot analysis
Rats were perfused transcardially with 100 ml of
saline to eliminate blood from nerve tissues after
anesthesia, and approximately 1.5 cm of both distal
and proximal nerve stumps was resected, stripped of
excess connective tissue, and immediately frozen in
liquid nitrogen. Total RNA was extracted from the
tissues with the Isogen RNA extraction kit. An equal
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amount of total RNA (10 Wg) for each sample was
separated by electrophoresis on agarose gels contain-
ing 0.6 M formaldehyde, and blotted on nylon mem-
brane ¢lters. Hybridization was carried out using a
full-length MIF cDNA probe radiolabeled with [K-
32P]dCTP in a solution containing 50% formamide,
0.75 M NaCl, 1% SDS, 20 mM Tris^HCl (pH 7.5),
2.5 mM EDTA, 0.5UDenhardt’s solution (1UDen-
hardt’s; 0.2% bovine serum albumin, 0.2% polyvinyl-
pyrrolidone, 0.2% Ficoll) and 10% dextran sulfate at
42‡C for 48 h. After hybridization, the ¢lters were
washed with 0.2Ustandard saline citrate (SSC)
(1USSC: 0.15 M NaCl, 0.015 M sodium citrate,
0.1% SDS) at 65‡C and then exposed to X-ray ¢lm
for 5 days with intensifying screens. Hybridization
signals were digitized and quanti¢ed by the computer
program, NIH image version 2.1. Background values
were determined from equivalent surface areas near
each hybridization signal and were subtracted from
each value before normalization.
3. Results
3.1. Identi¢cation of MIF protein in rat sciatic nerves
For Western blot analysis, transferred protein
bands of rat sciatic nerves were visualized by immu-
nostaining after the reaction with the anti-rat MIF
antibody (Fig. 1). A single band of the corresponding
molecular mass (approx. 12.5 kDa) speci¢c for MIF
was observed in the sample from the sciatic nerve. As
a positive control, recombinant rat MIF, brain and
spinal cord are shown. Pre-immune rabbit IgG did
not react with rat MIF in immunoblot analysis (data
not shown).
3.2. Detection of MIF mRNA in rat sciatic nerves
MIF mRNA expression in sciatic nerve tissues was
examined by RT^PCR analysis. Two Wg of the total
RNA was subjected to reverse transcription. From
the cDNA library prepared from a rat sciatic nerve,
the speci¢c transcript for rat MIF was ampli¢ed by
PCR. The expected nucleotide size (216 bp) of the
RT^PCR transcript was observed on agarose gel
(Fig. 2). As a positive control, rat brain and spinal
cord were used. The results showed that MIF mRNA
was constitutively expressed in the peripheral nerve
tissue.
3.3. Immunohistochemical localization of MIF in a
normal sciatic nerve
To identify the histological localization of MIF in
peripheral nerve tissues, immunohistochemical anal-
ysis was carried out. As positive controls, we used
anti-S100 and anti-neuro¢lament antibodies speci¢c
for Schwann cells and neuronal ¢bers, respectively.
Fig. 2. RT^PCR analysis of MIF in normal rat sciatic nerves.
Total RNA was extracted and cDNA was prepared as de-
scribed in Section 2. The transcript of MIF ampli¢ed by PCR
was analyzed by 2% agarose gel electrophoresis. Lane 1, rat
brain; lane 2, rat spinal cord; lane 3, rat sciatic nerves; lane 4,
molecular size markers (pBR322 DNA/MspI).
Fig. 1. Western blot analysis of normal rat sciatic nerves for
MIF. The tissue samples of rat sciatic nerves were collected,
electrophoresed, transferred to a nitrocellulose membrane and
visualized using a Konica HRP-100 immunostaining kit as de-
scribed in Section 2. Lane 1, recombinant rat MIF (100 ng);
lane 2, rat brain; lane 3, rat sciatic nerves; lane 4, rat spinal
cord; lane 5, pre-stained molecular marker (Biolabs).
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Fig. 3. Immunohistochemistry of the normal rat sciatic nerves. The transverse sections of nerves were stained with a Histo¢ne SAB-PO kit. Note the similar
immunostaining patterns of MIF and S-100 in normal sciatic nerves. (A) The tissue section was reacted with anti-rat polyclonal MIF antibody (arrows)
(U800). (B) The tissue section was reacted with non-immune rabbit IgG (U800). (C) The control positive staining for Schwann cells with anti-bovine polyclo-



































In Fig. 3, immunohistochemical localizations of
MIF, S-100 and neuro¢laments were demonstrated.
The immunostaining pattern of MIF (Fig. 3A) was
largely similar to that of S-100 in normal sciatic
nerves (Fig. 3C). Between the two immunopositive
stainings, however, we also observed some di¡eren-
Fig. 4. Immunohistochemistry of the rat sciatic nerves 4 days after transection using the anti-rat MIF antibody. The proximal and dis-
tal sections of nerves were stained with a Histo¢ne SAB-PO kit as described in Section 2. (A) A transverse section proximal to nerve
stumps. Note the positive immunostaining of axons (arrowheads) and Schwann cells (arrows) (U800). (B) A distal section transverse
to nerve stumps. Axonal degeneration and some positive immunostaining on endoneurial ¢broblasts or Schwann cells was observed
(arrows) (U800).
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ces in distribution and intensity, which may have
been due to the immunoreactivity of anti-MIF and
anti-S-100 antibodies or the diversity of the Schwann
cell population. No speci¢c positive staining was ob-
served when the tissue sample was reacted with non-
immune rabbit IgG (Fig. 3B). Underlying myelin
sheaths and axons lacked speci¢c MIF immunoreac-
tivity, whereas neuro¢laments were positively stained
by the anti-neuro¢lament antibody (Fig. 3D). These
results suggested that MIF protein was localized in
Schwann cells of normal sciatic nerves.
3.4. Immunohistochemical localization of MIF in
transected sciatic nerves
To determine the localization of MIF protein in
the transected peripheral nerves, we carried out im-
munohistochemical analysis of transected sciatic
nerve segments on day 4 after the operation. At the
proximal segments of transected nerves, positive
staining of MIF was observed in axons as well as
non-neuronal cells (Fig. 4A). On the other hand,
Schwann cells and endoneurial ¢broblasts that mi-
grated around neuronal ¢bers showed immunoreac-
tivity to MIF at distal segments su¡ering from Wal-
lerian degeneration (Fig. 4B). These ¢ndings were
clearly di¡erent from the localization of MIF in nor-
mal nerves.
3.5. Northern blot analysis of transected sciatic nerve
segments
We performed Northern blot analysis to clarify
changes of MIF mRNA expression in transected
nerves. The level of MIF mRNA in the proximal
segment, mainly expressed in axons and non-neuro-
nal cells, e.g., Schwann cells, started to increase 12 h
after nerve transection. In the distal segments, up-
regulation of the mRNA level, largely expressed in
Schwann cells and endoneurial ¢broblasts, was sim-
ilarly observed 12 h after the transection (Fig. 5A,B).
Then the level remained high from 24 h to 7 days
after injury. After this it decreased sharply between
14 and 21 days after transection. The results were
normalized by 18S RNA in gels stained with ethidi-
um bromide. The results showed that the MIF
mRNA expression level dynamically changed de-
pending on the stage of peripheral nerve degenera-
tion.
4. Discussion
Characteristic pathological changes such as phago-
cytosis of axonal debris and Schwann cell prolifer-
ation are observed in the process of peripheral nerve
degeneration and regeneration, and production of
various neurotrophic factors is induced. To date, a
large number of studies have reported on the roles of
neurotrophic factors during the process of peripheral
nerve degeneration^regeneration. In this process,
Schwann cells play an important role in nerve regen-
eration as a source of neurotrophic factors. It is of
note that macrophages play critical roles in both de-
generative and regenerative processes following pe-
ripheral nerve injuries.
Fig. 5. Detection of MIF mRNA in transected peripheral
nerves by Northern blot analysis. Total RNA was extracted
from rat sciatic nerves, and the radiolabeled full-length MIF
cDNA was used as a probe. Pictures of the ethidium bromide
gels are shown below to demonstrate the amount of total RNA
loaded (10 Wg per lane). Note the up-regulation of MIF mRNA
in both proximal and distal segments from 24 h to 7 days after
nerve transection. Time courses of MIF mRNA in sections
proximal (A) and distal (B) to nerve stumps. 1, 0 h; 2, 12 h; 3,
24 h; 4, 2 days; 5, 4 days; 6, 7 days; 7, 14 days; 8, 21 days.
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Recently, it has been reported that some pro-in-
£ammatory cytokines such as IL-1 [24], IL-6 [25,26]
and tumor necrosis factor (TNF)-K exhibit neurotro-
phic activity [27,28]. In the peripheral nervous sys-
tem, most of these cytokines are produced by
Schwann cells and up-regulated during the degener-
ation^regeneration period after nerve injury. Some of
them are considered to enhance the production of
neurotrophic factors by Schwann cells and macro-
phages. For instance, it has been reported that IL-1
produced by macrophages positively regulates the
synthesis of NGF in Schwann cells [11]; however,
their functions have been poorly understood in this
process.
It has been reported that MIF functions as a pro-
in£ammatory cytokine and immunoregulatory cyto-
kine [29]. A recent study indicated that MIF has the
potential to induce TNF-K secretion by macrophages
and promote nitric oxide production to synergize
with IFN-Q [14]. This ¢nding indicates that MIF
may act in concert with TNF-K and IFN-Q to ampli-
fy pro-in£ammatory responses of macrophages. On
the other hand, another unexpected MIF function in
association with wound healing was also reported in
the event of corneal injury [30]. As for the central
nervous system, in a similar manner, up-regulation of
MIF mRNA was observed in rat brain reperfusion
injury [31] and spinal cord injury [32]. In addition,
the immunoregulatory role of MIF in the central
nervous system was found to be pronounced by ex-
amining the production of MIF in response to lip-
opolysaccharide [33] and in view of its counter-regu-
latory function with regard to glucocorticoids [34].
Accordingly, it is hypothesized MIF may play a crit-
ical role during the regenerating process of peripheral
nerves via activation of other cytokines beyond the
immune system.
In this study, we demonstrated expression of MIF
in the peripheral nervous system by Western blot,
RT^PCR and immunohistochemical analyses. We
found that Schwann cells of peripheral nerves were
sources of MIF protein. It should be noted that the
tissue distribution of MIF was not uniform in the
case of nerve injury. Immunohistochemical localiza-
tion of MIF at day 4 after nerve transection showed
di¡erent features from normal nerves. At the distal
segments, MIF was observed in Schwann cells that
migrated to phagocytose myelin debris. On the other
hand, MIF was identi¢ed in axons as well as
Schwann cells at the proximal segments. It is of in-
terest that MIF expression was largely limited to
axons of the proximal segment, suggesting that pe-
ripheral nerve injury induces recruitment of macro-
phages in corresponding dorsal root ganglia [35].
From these facts, it appears that MIF is carried by
retrograde axonal transport after peripheral nerve
injury in a manner similar to CNTF [36].
Quantitative analysis of MIF mRNA by Northern
blotting exhibited a moderate level of MIF mRNA
12 h after nerve transection, whereas a high expres-
sion level was observed from 24 h to 7 days at either
the proximal or distal segment. There is often a time
lag of 2 to 3 days prior to an increase in the number
of in¢ltrating macrophages following peripheral
nerve injury [37^39]. This might be related to up-
regulation of MIF mRNA since at least 24 h elapsed
from the nerve injury. Moreover, the increase of
MIF mRNA corresponds to the period when macro-
phages are recruited to injured nerves. In this period,
it is speculated that MIF may regulate recruitment of
macrophages, which stimulates the release of neuro-
trophic factors, e.g., NGF, from Schwann cells.
Finally, we revealed the expression of MIF in rat
peripheral nerves, in which MIF might play an im-
portant role in the regeneration of peripheral nerves.
It has been indicated that MIF functions not only to
recruit macrophages to the in£ammatory site, but is
also involved in cell di¡erentiation [40]. As described
above, we identi¢ed the up-regulation of MIF
mRNA in reperfusion injury of the rat brain [31]
and corneal injury [16]. Taken together, these results
indicate it is very likely that MIF may be involved in
the mechanism of the wound-healing process beyond
the immune system. The precise pathophysiological
function of MIF in nerve regeneration remains un-
clear; however, the present results could contribute
to further understanding of MIF in relation to pe-
ripheral nerve degeneration and regeneration.
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